Loading...

Celularity Inc.

GXGXW•NASDAQ
Healthcare
Biotechnology
$1.70
$0.50(41.67%)

Celularity Inc. (GXGXW) Stock Overview

Explore Celularity Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 59.5/100

Key Financials

Market Cap237.7M
P/E Ratio-0.59
EPS (TTM)N/A
ROE-3.35%

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.88

GXGXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Celularity Inc. (GXGXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.59 and a market capitalization of 237.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for GXGXWStats details for GXGXW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for GXGXWAnalyst Recommendations details for GXGXW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

CEO

None

Headquarters

DE

Founded

2019

Frequently Asked Questions

;